Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07489144 · ClinicalTrials.gov registry record · NA
CO-creating Novel, Feasible, and Inclusive Research Methods
A NA study of Research Participation, sponsored by Augusta University.
- Active
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT07489144: Active NA study of Research Participation, sponsored by Augusta University.
NCT07489144 is a NA study of Research Participation that is active but no longer recruiting, run by Augusta University. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07489144, a NA study of Research Participation, is active but no longer recruiting, sponsored by Augusta University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The lessons we learn and evidence we discover from research studies are limited by who volunteered as participants in each research study. Currently, research studies do not represent the full diversity of the American people. Community engagement is one method to increase research participation. But, there is a lack of evidence for recommending a particular level of community engagement over others. Our team of scientists, physicians, and community members developed an innovative approach to increase full participation of participants in research studies. The proposed project, Co-creating Novel, Feasible, and Inclusive Research Methods (CONFIRM), is designed to test if we can increase research participation by creating methods in partnership with the research participants themselves. As our team has conducted research around breast cancer, we have repeatedly encountered Black women who see the importance of the overall topic and want to help people like them. But when they hear about what exactly they have to do as part of the study, they do not volunteer. We want to change that. We plan to recruit participants to answer research questions, and then with those volunteers, we will decide together on the tasks and activities volunteers will complete in the study. In contrast to how we usually do science, this innovative approach switches the order of design and participant recruitment. We enroll and engage volunteers before methods are selected. We engage research participants as "co-researchers." This word emphasizes the act of carrying out research with/by participants who are not professional researchers, instead of to/about/for them. We propose that participants will design a method that is acceptable, feasible, and relevant to themselves and their community. We will recruit 240 participants from community sites, such as health fairs, retail stores, churches, and schools, who will be divided into two groups based on where they signed up for the study. Half of t
Primary Outcome
Percent of participants who complete study across two data collection cycles
Conditions Studied
Interventions
- OTHER Participant co-design
Study Locations (1)
Georgia
- Augusta University - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2025-06-21 |
| Est. Completion | 2027-11-30 |
| Phase | NA |
What the registry record for NCT07489144 still lists
NCT07489144 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Research Participation appearing as the primary indexed condition, and to 1 intervention - of which Participant co-design is the first listed.
NCT07489144 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT07489144 about?
NCT07489144 is a clinical study titled "CO-creating Novel, Feasible, and Inclusive Research Methods". The lessons we learn and evidence we discover from research studies are limited by who volunteered as participants in each research study. Currently, research studies do not represent the full diversity of the American people. Community engagement is one method to increase research participation. Bu...
What is the current status of trial NCT07489144?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2025-06-21. Estimated completion is 2027-11-30.
What conditions does trial NCT07489144 study?
This clinical trial studies the following conditions: Research Participation.
What interventions are being tested in trial NCT07489144?
The interventions under investigation include: Participant co-design (OTHER).
Who is sponsoring clinical trial NCT07489144?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07489144 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07489144's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI